# Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin

> **NCT01775839** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 24 (actual)

## Conditions studied

- DRUG REACTIONS

## Interventions

- **DRUG:** Aspirin+Clopidogrel/Digoxin(oral)
- **DRUG:** Aspirin+Clopidogrel/Digoxin(IV)

## Key facts

- **NCT ID:** NCT01775839
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2014-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01775839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01775839, "Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of Digoxin". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT01775839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*